NCT06646822

Brief Summary

Stimulants are dangerous drugs that are commonly abused by individuals looking to stay alert and focused, lose weight, stay awake, and get high. Although these drugs can be extremely harmful and even life-threatening, many of them can also be used to treat conditions like ADHD, narcolepsy, and in some cases, depression. There are many types of stimulant drugs, and it can be beneficial to know a little about each one, its purposes, and how harmful it can be when abused. Illicit stimulants are usually schedule II, depending on whether or not they can be used to treat medical conditions. While some variations of stimulants are schedule I drugs, most are extremely addictive and dangerous schedule II substances. These drugs are often abused in a binge-crash pattern. According to the NIDA Teen, "In order to keep the 'high' going, people may take the drug repeatedly within a short period of time, at increasingly higher doses." This makes these drugs extremely addictive. The aim of this survey to detect prevalence of non prescription stimulants in Egyptian students and increase their awareness of the harmful effects of these drugs.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 10, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

October 2, 2025

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

October 9, 2024

Last Update Submit

September 27, 2025

Conditions

Keywords

PrevalenceawarenessattitudesStimulant drugEgyptian universities

Outcome Measures

Primary Outcomes (2)

  • Prevalence/ pattern

    * \- Do/ did you use stimulants ( Recreational drugs): Yes No * How do / did you obtain this medication Prescribed Non prescribed * When did you start receiving stimulants for last 1 year for last 3 years for last 5 years * Which Stimulant (drug) is/ was used * tobacco products (e.g., coffee, chocolate, cigarettes) high caffeine products * pseudoephedrine, ( nasal decongestant) * methylphenidate \[Ritalin\] * amphetamine \[Adderall\] * methamphetamine * modafinil (Provigil) * dextroamphetamine (Dexedrine) * dextro/levoamphetamine (Adderall) * adrafinil (Olmifon) * piracetam * Others

    1 year

  • Awareness/ attitude

    \- How do you know about the effect of stimulants: Substance use by peers Friends as a source of prescription stimulants Social media Promotion * Why do you use stimulant Because it helps me concentrate Because it helps me study and enhance memory Because it helps increase my alertness and concentration Because it gives me a high mood Because it helps me to be more energetic Because it improves sleep quality Because it decreases stress level Because of experimentation Because it helps me lose weight * Do you know that stimulant is harmful to the body systems Yes No * Which of the following side effects do you experience after using stimulant * decreased appetite * weight loss * headache * insomnia * dizziness * nervousness. * Seizures * cardiac events (increase blood pressure and heart rate, heart attacks) * psychosis * Did you receive treatment for the side effects after using stimulants Yes No

    1 year

Secondary Outcomes (1)

  • Demographic data

    1 year

Study Arms (1)

study group

Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice.

Other: questionnaire

Interventions

observational study

study group

Eligibility Criteria

Age18 Years - 30 Years
Sexall(Gender-based eligibility)
Gender Eligibility Details18-30
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Undergraduate students at a large public university in Egypt who were 18 years of age or older took the survey in 2024. All survey and recruitment materials were approved by Minia University, faculty of pharmacy. Students were received survey through email. Students took the survey online at a time and location of their choice. No time limit was imposed.

You may qualify if:

  • \- Academic student Age (18-30) years Included in medical faculty

You may not qualify if:

  • Not undergraduates student Aged \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asmaa Ahmed Hamed

Minya, 11666, Egypt

Location

MeSH Terms

Conditions

Behavior

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

October 9, 2024

First Posted

October 17, 2024

Study Start

December 10, 2024

Primary Completion

April 30, 2025

Study Completion

November 30, 2025

Last Updated

October 2, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations